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Abstract
Backgrounds: Radioactive tracer-based detection has been proposed as a standard procedure in identifying
sentinel nodes for cN0 oral/oropharyngeal carcinoma. However, access to radioactive isotopes may be limited in
some surgical centers, and there is potential risk of the radioactive tracers to the operators. This study was designed
to evaluate the feasibility of near-infrared fluorescence imaging with indocyanine green combined with blue dye
mapping in sentinel node biopsy for cN0 oral/oropharyngeal carcinoma.
Methods: Twenty-six cases of previously untreated oral/oropharyngeal carcinoma staged cT1-2N0M0 were enrolled
in this study. One milliliter of indocyanine green (5 mg/ml) and 1.5 ml of methylene blue (1 mg/ml) were injected
sequentially around the primary tumor in a four-quadrant pattern before skin incision. After elevation of the
platysma flap and posterior retraction of the sternocleidomastoid muscle, fluorescence images were taken with a
near-infrared detector, with special attention paid to any blue-dyed lymph nodes. Lymph nodes identified first with
fluorescent hot spots with or without blue dye were defined as sentinel nodes, and they were harvested and sent
for pathologic study.
Results: Sentinel nodes were successfully harvested in all 26 cases. The number of sentinel nodes (SNs) per case
varied from 1 to 9, with an average of 3.4. Routine pathology demonstrated occult metastasis exclusively in SNs in
four cases (15.4 %). No tracer-associated side effects occurred in this series.
Conclusions: Near-infrared imaging using indocyanine green combined with methylene blue mapping is a feasible
and reliable new method for SN biopsy in cN0 oral/oropharyngeal carcinoma.
Keywords: Sentinel node biopsy, Indocyanine green, Near-infrared fluorescence, Oral neoplasms, Oropharyngeal
neoplasms, Methylene blue
Background
Management of the clinically negative neck (cN0) in
oral/oropharyngeal squamous cell carcinoma remains a
dilemma. Because there is no diagnostic test available
that can accurately evaluate cervical lymph node meta-
static status, management options for this situation
have included elective neck dissection or watchful wait-
ing [1–3]. However, studies demonstrate that 20–40 %
of cN0 patients have occult cervical metastases and will
inevitably develop cervical recurrence if a watchful
waiting policy is followed; on the other hand, the 60–80 %
of patients who have truly negative neck nodes will risk
unnecessary injury if an elective neck dissection is per-
formed. Heretofore, selective neck dissection (SND), a
procedure that is less invasive than radical neck dissection
or modified neck dissection, is widely accepted as the gold
standard for management of cN0 neck of oral/oropharyn-
geal cancer [1, 4–8].
In the past two decades, sentinel node biopsy (SNB)
has been proposed as a promising minimally invasive
procedure for management of the cN0 neck of oral/oro-
pharyngeal carcinoma [1, 9, 10]. SNB allows the surgeon
to identify and harvest the upper echelon lymph nodes
that drain the site of a primary malignancy. Further-
more, SNB allows the pathologist to focus on a few
lymph nodes and make further pathologic analysis of
both clinically occult micro- and macro-metastases. Use
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of this technique may avoid overtreatment of oral/oro-
pharyngeal carcinoma with pathologically N0 neck.
SNB is a more minimally invasive procedure than
SND, and it has higher sensitivity and specificity for
evaluating the metastatic status of the cN0 neck in oral/
oropharyngeal carcinoma compared to traditional phys-
ical examination and imaging scans (CT, MRI, or PET/
CT) or image-guided FNA [1, 9, 10]. Although SNB has
been administered as a routine procedure in breast
cancer, skin melanoma, and vulvar carcinoma in many
centers worldwide, its use in head and neck mucosal
cancers is much less common, likely because of chal-
lenges with regard to sentinel node (SN) detection tech-
niques when applied to the head and neck [11–14].
Preoperative lymphoscintigraphy and intraoperative γ
probe detection or blue dye mapping is the most com-
monly used technique for SNB in head and neck mucosal
cancers [7, 12]. However, the access of radioactive isotopes
is limited in many surgical units, and there is potential risk
of the radioactive tracers to the operators. We have previ-
ously performed studies of SNB in oral tongue cancers
using preoperative lymphoscintigraphy combined with in-
traoperative Methylene blue dye mapping or with intraop-
erative γ probe and achieved encouraging results [15–18].
However, because of the inconvenience of the proced-
ure and potential hazards of the radioactive tracer, we
attempted to look for an alternative technique which
would be accurate, convenient, and safe.
Near-infrared fluorescence (NIF) imaging is a newly
developed SNB technique firstly introduced by Kitai et
al. in 2005 [19]. Subsequent reports of its successful use
in gastric, gynecologic, lung, esophagus, as well as skin
cancer are found in the literature [20–22]. To our know-
ledge, there are only a few pilot studies of SNB with NIF
mapping for head and neck mucosal cancer that have
been published, which have demonstrated the proof of
principle and safety of this technique; however, the largest
subject sample size was only 14 cases [23–26]. Clearly,
further studies with more patients are needed to estab-
lish the feasibility and reliability of NIF imaging with
indocyanine green (ICG) for evaluating the cervical
lymph node status of cN0 head and neck mucosal can-
cers. In the current study, we report our results of SNB
for 26 cases of cN0 oral/oropharyngeal carcinoma using
NIF imaging with ICG combined with methylene blue
mapping. Considering the higher possibility of occult
metastasis in cT3–4 cases, similar to other studies, we
included only cT1-2N0M0 patients in the current
study.
Methods
Patients with previously untreated cT1-2N0M0 oral or
oropharyngeal cancer who were to undergo selective
neck dissection (levels I–III) or modified radical neck
dissection plus radical resection of the primary tumor
with or without reconstruction were enrolled in this
study. Exclusion criteria were age <18, having a history
of previous neck surgery or radiotherapy; pregnancy;
lactation; or an allergy to iodine, shellfish, or ICG.
Clinical stage was based on physical examination and
imaging studies (CT or MRI with contrast).
This study was conducted with the approval of Med-
ical Ethics Committee of Cancer Hospital of Shantou
University Medical College and was performed in ac-
cordance with the ethical standards of the Helsinki
Declaration of 1975. Written informed consent was
obtained from all patients before SNB.
SN mapping was performed using the Optical Molecu-
lar Imaging Operation Navigation System (OMIONS,
Zhongke Medical Imaging Technology Co. Ltd., Anhui,
China). The system consists of two wavelength-isolated
light sources: a “white” light source, generating 400–
650 nm light and a “near-infrared” light source, generat-
ing 760 nm light. Color video and NIR fluorescence im-
ages are simultaneously acquired and displayed in real
time using custom optics and software that separate the
color video and NIF images. The imaging head is attached
to a flexible double-joint arm, which permits positioning
of the imaging head virtually anywhere over the surgical
field [27].
The ICG (Dandong, China) was dissolved at a concen-
tration of 5 mg/ml, and the methylene blue (Beijing,
China) was prepared at a concentration of 10 mg/ml.
One milliliter of ICG was injected around the tumor in
a four-quadrant pattern (Fig. 1); 1.5 ml of methylene
blue was then injected in the same manner. Immediately
after injection of the tracers, a standard incision was
made and the platysma flap was elevated. After exposure
of the subplatysmal plane in the neck and retraction of the
sternocleidomastoid muscle posteriorly, the surgical field
Fig. 1 One milliliter of indocyanine green at a concentration of
5 mg/ml was injected around the tumor in a four-quadrant pattern
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was measured for fluorescent signal using the OMIONS.
During neck dissection, measurement of fluorescence was
performed every 5 to 10 min until hot spot(s) appeared on
the screen. Special attention was paid to the blue-dyed
lymphatics and lymph nodes. The first appearing lymph
nodes with NIF hot spots with or without visible blue dye
were defined as SNs and were resected for further con-
firmation under the OMIONS (Figs. 2, 3, 4, and 5). Neck
dissection was continued after harvest of the SNs; any
blue-dyed lymphatic at this point was considered to be
second station lymph nodes rather than SNs, and they
were separately sent for pathologic analysis. The resection
of the primary tumor was subsequently performed by
standard procedure; reconstruction of the defect was done
as indicated. The harvested SNs were bisected along the
long axis through their hilum; one half was fixed in forma-
lin, embedded in paraffin, and sent for routine pathologic
examination; the other half was deposited in liquid nitro-
gen for further investigation. All non-SNs were examined
by routine histopathological analysis.
Results
Patient and tumor features
Clinical data of the patients are detailed in Table 1. A
total of 26 consecutive patients with squamous cell car-
cinoma of the oral cavity (n = 19) or oropharynx (n = 7)
and a clinical stage of T1-3N0M0 were enrolled in this
study from July 2014 to December 2014. Median pa-
tient age was 60.5 years (range 43–77 years). Fifteen
patients had cT1 primary, eleven patients had cT2.
Fig. 2 After exposure of the subplatysmal plane in the neck and
retraction of the sternocleidomastoid muscle posteriorly, fluorescent
hot spots appeared under “near-infrared” light source
Fig. 3 Color image of the sentinel nodes under “white” light source
shows visible blue dye
Fig. 4 Ex vivo sentinel nodes with or without blue dye
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Location of primary tumor included oral tongue (n =
14), buccal mucosa (n = 3), palatoglossal arch (n = 3),
base of the tongue (n = 3), hard palate (n = 2), and soft
palate (n = 1). All patients underwent a radical resec-
tion of the primary tumor with negative surgical mar-
gins. Of the 26 patients, eleven needed a surgical
reconstruction (radial forearm flap, n = 7; infrahyoid
myocutaneous flap, n = 2; local mucosal flap, n = 1; skin
graft, n = 1), whereas primary closure was possible for
the remaining patients. Ipsilateral SND was performed
in 20 patients, modified radical neck dissection (MRND)
was performed in 5 patients, and bilateral SND was
performed in 1 patient; selection of an appropriate ND
type was based on clinical indications. The sentinel node
excision was performed prior to the reconstructive sur-
gery; SNB did not have any impact on reconstruction.
There were no complications associated with the tech-
nique. SNB added an average of about 15 min to the total
operation time compared with a standard neck dissection
procedure.
At least 1 SN was successfully detected in all 26 patients.
A total of 88 SNs were harvested, with a SN number per
case of 1-9, average of 3.4 SNs. The number of non-SNs
was 498 in 26 cases, with an average of 19.2 per case. All
the SNs were detected in the ipsilateral neck; anatomic
distribution of these 88 SNs was as follows: level IIa
63.6 % (56/88), level Ib 17.0 % (15/88), level III 11.4 % (10/
88), and level Ia 8.0 % (7/88).
Routine histological analysis of the neck dissection spec-
imens demonstrated that four patients had occult lymph
node metastasis (15.4 %), and all the metastatic tumors
were found exclusively in SNs. Nodal classification was
elevated from cN0 to pN1 and pN2 both in two patients.
Additional blue-dyed lymph nodes after removal of the
SNs were found in 11 patients. All these lymph nodes
were free from metastasis under routine pathology.
No side effects associated with ICG injection were
observed in this series.
Discussion
Although multiple studies have demonstrated the po-
tential benefit of SNB in head and neck cancers, only a
few centers have used this technique to determine the
necessity of neck dissection for cN0 head and neck can-
cers, due to several possible reasons including the com-
plex lymphatic anatomy of the head and neck and less
accessibility of the primary tumor location [28]. With
regard to SN detection techniques, preoperative lym-
phoscintigraphy, intraoperative γ probe detection, with
or without blue dye mapping, is now considered the
gold standard method [12, 29, 30]. However, several
disadvantages of this standard procedure are notable:
(1) SNB using radioactive tracers requires a nuclear
physician, and both the staff and patient are exposed to
radiation although the dose is much lower than the
maximum safe limit; (2) the use of radioactive tracer is
also associated with the need to safely dispose of any
contaminated waste; (3) preoperative lymphoscintigraphy
entails an additional procedure for the patient which in-
creases the overall cost of care; furthermore, the lymphos-
cintigraphy injection is done while patients are awake
which may provoke pain and anxiety for some; (4) the so-
called shine-through phenomenon handicaps SN detec-
tion when the primary site and the possible SNs are in
close anatomic proximity, e.g., cancer of the floor of the
mouth [5, 12]; and (5) blue dye also has disadvantages,
in that blue-dyed SNs can only be identified when the
lymphatic or lymph nodes are surgically exposed. Thus,
developing a novel alternative to overcome these pitfalls
without compromising diagnostic reliability could in-
crease the acceptance and use of SNB for head and
neck cancer. We hypothesize that intraoperative NIF
imaging with ICG combined with blue dye mapping is
a SNB technique that is a potential alternative to the
current gold standard of isotope detection.
ICG has been used extensively in the medical field
since 1957 [31]. It is now widely used in measurement
of liver/renal function, retinal angiography, cardiac out-
put, as well as perforator detection in flap harvest and
monitoring [32]. As soon as ICG is infused intraven-
ously, it rapidly binds to plasma proteins and thereby is
confined to the vascular space. ICG is removed exclu-
sively by the liver at the rate of 18–24 % per minute with
a half-life of 150–180 s [22]. The clinical use of ICG in
detection of SN successfully was first introduced by Kitai
Fig. 5 Ex vivo confirmation using OMIONS showed all sentinel
nodes had fluorescent hot spots
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in breast cancer [19]. To our knowledge, only a few stud-
ies on SNB for head and neck mucosal carcinoma using
NIF imaging with ICG have been reported in the
English literature, and the results show potential feasi-
bility [23–26, 28]. However, further studies are needed
to verify the feasibility, efficacy, and optimal protocol
for this technique.
Drawing from our previous experience doing SNB for
oral cancer using radioactive tracer and blue dye mapping,
we performed the current study to evaluate the feasibility
and efficacy of SNB using NIF imaging combined with
methylene blue dye mapping for oral/oropharyngeal
carcinoma. The fluorescent signals were successfully
captured after elevation of the platysma flap and posterior
retraction of the sternocleidomastoid muscle in all 26
cases. SNs in 15 cases were also visibly blue dyed. In a
study using ICG with blue dye in SNB for breast cancer,
Hirono et al. defined both fluorescence positive and blue-
dyed lymph nodes as SN [33]. However, we surmise that
migration of ICG from the primary to the SNs is in the
same manner as but faster than that of methylene blue
[20], resulting in a proportion of SNs that concentrate
only detectable ICG without visually detectable level of
methylene blue. All the blue-dyed lymph node(s) identi-
fied after fluorescence hot spots were free from metastasis,
supporting the rationale of the SN definition used in this
series: the lymph node(s) with hot spots detected first
were defined as SN. Anatomic distribution of the SNs in
the current study was similar to the metastatic pattern of
oral/oropharyngeal cancer in our early retrospective study
[34]: most frequently in ipsilateral level IIa (63.6 %, 56/88),
followed by level I (25.0 %, 22/88), finally level III (11.4 %,
Table 1 Clinical data of the patients enrolled
Pt No. Age Sex Primary site cTNM ND type Reconstruction pTNM SN site SN no. (p+/total) Other LN no.
1 63 M Palate T1N0M0 SND Local mucosal flap T1N0M0 IIa 0/2 0/12
2 55 F PGA T1N0M0 MRND RFAF T1N2M0 IIa, III 2/3, 0/2 0/19
3 51 F Tongue T1N0M0 MRND None T1N0M0 IIa 0/6 0/22
4 59 M BOT T2N0M0 SND None T3N0M0 IIa 0/2 0/25
5 72 M Buccal T2N0M0 SND None T2N0M0 Ib 0/1 0/9
6 71 F Tongue T2N0M0 SND None T3N0M0 IIa 0/3 0/24
7 57 M Buccal T2N0M0 SND None T3N1M0 Ib 1/1 0/17
8 55 M Tongue T1N0M0 SND IHMCF T1N2MO Ib, IIa 1/2, 2/3 0/26
9 66 F Tongue T1N0M0 SND None T1N0M0 IIa 0/3 0/24
10 49 M PGA T1N0M0 MRND RFAF T1N0M0 IIa 0/9 0/17
11 56 M Tongue T1N0M0 SND None T1N0M0 Ib, IIa 0/1, 0/2 0/13
12 45 F Palate T2N0M0 SND RFAF T2N0M0 IIa 0/1 0/14
13 72 M PGA T1N0M0 MRND RFAF T1N0M0 IIa 0/5 0/19
14 53 F Tongue T1N0M0 SND None T1N0M0 Ib, IIa 0/2, 0/2 0/12
15 73 M Buccal T1N0M0 SND Skin graft T1N0M0 Ib 0/6 0/12
16 47 M BOT T1N0M0 bi-SND IHMCF T1N0M0 Ia 0/1 0/30
17 75 F Tongue T1N0M0 SND None T1N0M0 IIa 0/2 0/9
18 73 M Soft palate T1N0M0 SND RFAF T1N0M0 IIa 0/1 0/11
19 77 F Tongue T2N0M0 SND None T2N0M0 Ia, IIa 0/2, 0/3 0/17
20 55 F Tongue T2N0M0 MRND None T3N0M0 Ia, III 0/2, 0/2 0/39
21 64 M Tongue T1N0M0 SND None T1N1M0 Ib,IIa 1/1, 0/2 0/20
22 56 M BOT T2N0M0 SND RFAF T2N0M0 IIa, III 0/1, 0/3 0/18
23 76 F Tongue T2N0M0 SND None T2N0M0 IIa 0/1 0/29
24 50 F Tongue T2N0M0 SND None T2N0M0 Ib, IIa 0/2, 0/2 0/20
25 68 F Tongue T2N0M0 SND None T2N0M0 Ia, IIa 0/1, 0/2 0/17
26 62 F Tongue T1N0M0 SND None T1N0M0 Ia, III 0/1, 0/3 0/23
Abbreviations: ND neck dissection, SN sentinel node, LN lymph node, p+ pathologically positive, M male, F female, SND selective neck dissection, bi-SND bilateral
selective neck dissection, cSND contralateral selective neck dissection, PGA palatoglossal arch, MRND modified radical neck dissection, RFAF radial forearm flap,
BOT base of the tongue, IHMCF infrahyoid myocutaneous flap
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10/88). The average number of SNs harvested in this study
was higher than our previous study using radioactive
tracer (3.4 per case vs. 2.0 per case) [16, 17].
There are several advantages of this technique com-
pared with standard SNB with radioactive tracers. (1)
ICG is a radiation-free tracer and safe, rare side effects
have been reported, and special radiation protection is
unnecessary. (2) SNB using NIF imaging with ICG is a
convenient one-step procedure; patients’ discomfort and
anxiety during preoperative injection of the tracer for
lymphoscintigraphy can be avoided. (3) The cost of a full
dose of ICG is much less than a radiotracer, and the
fluorescence imaging device is also less expensive than a
γ probe; therefore, as a result of the lower cost, patients
in developing countries may also benefit from SNB with
ICG. (4) With stimulation of near-infrared light, the
fluorescent signal of the ICG was detectable after platys-
mal flap elevation and posterior retraction of the sterno-
cleidomastoid muscle, making it easy for a surgeon to
remove the SNs; as demonstrated in this study, SNs were
successfully identified in all 26 cases. (5) SNs harvested
with this technique represent the first echelon nodes
that drain the primary site. In the current study, we
demonstrated that fluorescence positive SNs accurately
determined the cervical lymph node metastatic status in
all 26 cases, without any false negatives.
In this study, selective or modified radical neck dissec-
tions were still performed in all patients. Our results
suggest removal of sentinel nodes alone could reliably
demonstrate the cervical nodal status for these tumors.
If comprehensive neck dissection could be limited to
those with positive sentinel nodes, the potential morbid-
ity of this surgical procedure would be avoided and the
cost and length of hospital stay might be reduced.
Interestingly, the average number of SNs harvested in
our study is higher than other reports [33]. We believe
that this may be related to the sensitivity of the OMIONS.
Since quantification of the NIF is not possible using the
current generation of OMIONS, we harvested all lymph
nodes with any visible fluorescent signal.
Another previously reported advantage of SNB with
ICG fluorescent imaging in superficial cancers is that it
enables visualization of lymphatic drainage from the
primary tumor to the regional lymph node basin. Thus,
SNs can be identified and resected more rapidly and
easily, especially in cases with multiple lymphatic drain-
age pathways [35]. However, this advantage was not
observed in our study. We failed in attempts to meas-
ure fluorescent signal transcutaneously in all the first
five cases. A possible explanation is that the penetrating
thickness through soft tissues of NIF from ICG is 0.5–
1 cm [32, 35], whereas oral cavity and oropharyngeal
lymphatic channels and SNs are usually embedded in
the deep fatty tissue and blocked by either mandible or
sternocleidomastoid muscle, making it impossible for the
CCD camera to capture the NIF signal transcutaneously.
The inability to detect NIF signal transcutaneously
does mean that an initial neck incision of sufficient
length must be made to allow exposure of the expected
neck levels where the sentinel nodes are likely located,
which is an acknowledged drawback of this technique. In
comparison, with the radioactive tracer/γ-probe tech-
nique, transcutaneous detection allows one to make a
small skin incision over the target sentinel nodes. Another
drawback of this technique is that shadowless lights in the
operating theater give off their own intrinsic NIF beam;
therefore, lymphatic navigation must be performed in the
dark to minimize the interference with beams produced
by the ICG.
Conclusions
Based on the results of our study, which is the largest series
reported to date, we conclude that NIF imaging with ICG
to identify the SNs in oral/oropharyngeal cancer is feasible,
reliable, and safe. SNB using this technique correctly evalu-
ates the cervical node status as confirmed on routine path-
ology of complete neck dissection specimens. NIF imaging
with ICG is a promising SNB technique for oral/oropharyn-
geal cancer that deserves further research to refine the
technique. Future consideration should be given to a pro-
spective trial comparison of NIF imaging with ICG versus
radioisotope techniques for sentinel node identification in
oral cancer.
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